Skip to main content

Is taro.com a Scam? Security Check Results - Taro Pharmaceutical Industries Ltd.

taro.com favicon

Is taro.com Safe? Security Analysis for Taro Pharmaceutical Industries Ltd.

https://taro.com

Check if taro.com is a scam or legitimate. Free security scan and reviews.

HealthcareUnited Stateslarge
jQuery 1.7.2Drupal 7jQuery DC Mega MenujQuery mmenujQuery zAccordion+1 more
Analyzed 9/7/2025Completed 5:46:23 AM
66
Security Score
MEDIUM RISK
Exclusive insights unlocked

Unlock the complete security report for taro.com

Get full access to AI recommendations, compliance evidence, vulnerability remediation steps, and downloadable PDF reports. Upgrade once for lifetime access to this scan.

Full Report Access

All modules, AI insights, PDF download

39.90 €one-time • Incl. 21% VAT

Marketing Intelligence

Contact emails, phone numbers & warm leads

49.90 €one-time • Incl. 21% VAT

How it works

  1. Enter your email to receive the unlocked report.
  2. Complete the secure EveryPay checkout (cards & local methods supported).
  3. You’ll receive an email with your unique unlock code and the PDF export.

Already purchased?

Order summary

Domaintaro.com
Access tierFull report or marketing add-on

Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.

VisaMastercardApple PayGoogle Pay

Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.

SEQ SIA

Lastadijas 12 k-3, Riga, Latvia, LV-1050

Reg. No. 40203410806 • VAT LV40203410806

Support: guard@offseq.com+371 2256 5353

AI Summary

Taro Pharmaceutical Industries Ltd. is a well-established pharmaceutical company specializing in topical prescription products and other pharmaceutical offerings. The company is now a wholly owned subsidiary of Sun Pharm… Unlock the full Guard report to read the complete analysis.

Detected Technologies

jQuery 1.7.2Drupal 7jQuery DC Mega MenujQuery mmenujQuery zAccordioneasyResponsiveTabs
Continuous monitoring

Keep taro.com under constant watch

Guard tracks your live infrastructure daily: certificate expiry, DNS & mail authentication drift, uptime changes, subdomain inventory, and unexpected tracker or content shifts. A full timeline captures every diff so you can prove remediation and spot regressions instantly.

Security drift alerts

Risk score drops, new high-severity issues, and header hardening gaps

Compliance watch

GDPR / NIS2 posture changes with governance evidence snapshots

Infrastructure surface

Unexpected open services, SSL expiry, DNS & email authentication changes

Content & tracker intelligence

Marketing tech shifts, analytics drift, and AI recommendation updates

25 €
per month · billed securely via EveryPay

Cancel anytime. Alerts sent to the contacts you choose. Unlock the full report to view historical timelines and alerts.

Unlock the full Guard report to view the monitoring timeline, JSON diffs, and alert history for taro.com.

Security Headers

5 findings

60/100

GDPR Compliance

4 findings

53/100

NIS2 Compliance

9 findings

2/100

Email Security

2 findings

87/100

🧠AI Business Intelligence

Technology stack, business insights, and market analysis powered by AI.

Snapshot shown below. Unlock the full AI report for complete market insights, audience profiling, and step-by-step recommendations.

Business Intelligence

Market & Strategic Analysis

Taro Pharmaceutical Industries operates in the healthcare sector with a focus on pharmaceutical manufacturing and research. Its ownership by Sun Pharma positions it strongly in the global pharmaceutical market. The company maintains multiple subsidiaries targeting different geographic markets including the USA, Canada, Israel, and international markets. The website supports investor relations and corporate communications, indicating a transparent and mature business model. The partnership ecosystem includes Sun Pharma and affiliated companies like Chattem Chemicals. The company targets healthcare professionals, investors, and consumers, leveraging its research capabilities and product portfolio to maintain competitive advantage. Growth indicators include recent merger announcements and active investor communications.

Security Posture Analysis

Comprehensive Security Assessment

The current security posture is moderate but with notable gaps. The domain is secured with transfer and update prohibitions, indicating good domain management. However, the absence of DNSSEC and security headers reduces protection against DNS spoofing and common web attacks. The use of outdated jQuery 1.7.2 introduces potential vulnerabilities. No public security or incident response policies are available, and no dedicated security contact channels were found. Privacy compliance is partial, lacking cookie consent mechanisms. Overall, the site is functional and legitimate but requires improvements to meet modern security and privacy standards.

Strategic Recommendations

Priority Actions for Security Improvement

1

Upgrade to the full Guard report to access tailored remediation steps.

Observations

AI-powered comprehensive website and business analysis.

A preview of your strategic observations is visible. Upgrade to unlock the full competitive positioning, trust signals, and branding checklist.

AI-Enhanced Website Analysis

Business Insights

Company:

Taro Pharmaceutical Industries Ltd.

Description:

Taro Pharmaceutical Industries is a pharmaceutical company specializing in topical prescription products and other pharmaceutical offerings. It is now a privately held company wholly owned by Sun Pharma, a global healthcare company with innovative therapies, generic medicines, and consumer healthcare products.

Key Services:
Pharmaceutical product manufacturingResearch and developmentInvestor relations
Content Quality:

good

Branding:

consistent

Technical Stack

Technologies:
jQuery 1.7.2Drupal 7jQuery DC Mega MenujQuery mmenujQuery zAccordioneasyResponsiveTabs
Frameworks:
Drupal 7
Performance:

moderate

Mobile:

good

Accessibility:

basic

SEO:

basic

Security Assessment

Security Score:
55/100
Best Practices:
  • Domain status includes clientTransferProhibited and serverUpdate/Delete/TransferProhibited flags

Analytics & Tracking

Tracking Level:minimal
Privacy Compliance:basic

Advertising & Marketing

Transparency Level:poor

Website Quality Assessment

Design Quality:good
User Experience:good
Content Relevance:good
Navigation Clarity:good
Professionalism:good
Trustworthiness:high

Key Observations

1

Website is a corporate pharmaceutical site with clear business focus.

🛡️Security Headers

HTTP security headers analysis and recommendations.

Some header findings are shown. Unlock to see the full checklist, impacted endpoints, and remediation guidance.

Security Headers

HTTP security headers analysis

60/100
Score

Weak X-Content-Type-Options configuration

LOW

Current value: "nosniff, nosniff" Unlock the full report to read the complete fix.

Missing Content-Security-Policy header

HIGH

Controls resources the browser is allowed to load Unlock the full report to read the complete fix.

Missing X-XSS-Protection header

MEDIUM

Legacy XSS protection (deprecated but still recommended) Unlock the full report to read the complete fix.

Missing Referrer-Policy header

LOW

Controls referrer information sent with requests Unlock the full report to read the complete fix.

Sensitive data may be cached

LOW

Cache-Control header should include "no-store" for sensitive pages Unlock the full report to read the complete fix.

👤GDPR Compliance

Privacy and data protection assessment under GDPR regulations.

Preview of GDPR checkpoints is visible. Unlock to reveal full evidence, policy excerpts, and DPIA guidance.

GDPR Compliance

Privacy and data protection assessment

53/100
Score

No Cookie Policy found

HIGH

GDPR requires clear information about cookie usage Unlock the full report to read the complete fix.

No Cookie Consent Banner found

HIGH

GDPR requires explicit consent for non-essential cookies Unlock the full report to read the complete fix.

No Data Protection Officer mentioned

LOW

Large organizations may need to designate a DPO under GDPR Unlock the full report to read the complete fix.

Privacy policy may not be GDPR compliant

MEDIUM

Privacy policy lacks explicit GDPR compliance elements Unlock the full report to read the complete fix.

GDPR Compliance Analysis

Privacy Policy85% confidence
Cookie Policy0% confidence
Contact Information Found90% confidence
phone

🛡️NIS2 Compliance

Network & Information Security Directive compliance assessment.

You can see headline NIS2 checks. Upgrade to access the full control mapping, severity breakdown, and remediation plan.

NIS2 Compliance

Network & Information Security Directive

2/100
Score

No information security framework found

HIGH

NIS2 requires documented cybersecurity and information security measures Unlock the full report to read the complete fix.

No vulnerability disclosure policy

MEDIUM

NIS2 encourages coordinated vulnerability disclosure Unlock the full report to read the complete fix.

No security policy documentation found

HIGH

NIS2 requires documented cybersecurity governance and risk management Unlock the full report to read the complete fix.

No incident response procedures found

HIGH

NIS2 requires documented incident response and business continuity plans Unlock the full report to read the complete fix.

No business continuity planning found

MEDIUM

NIS2 emphasizes operational resilience and business continuity Unlock the full report to read the complete fix.

No security contact information

HIGH

NIS2 requires clear incident reporting channels Unlock the full report to read the complete fix.

No vulnerability reporting mechanism

MEDIUM

Clear vulnerability reporting supports coordinated disclosure Unlock the full report to read the complete fix.

No NIS2 reference found

LOW

Consider explicitly mentioning NIS2 compliance efforts Unlock the full report to read the complete fix.

Critical sector without clear security compliance

HIGH

Detected sectors: transport, banking, health, digital Unlock the full report to read the complete fix.

📧Email Security

SPF, DKIM, and DMARC validation and email security assessment.

Quick view of email authentication checks is provided. Unlock to uncover full DNS evidence, record diffs, and fix scripts.

Email Security

SPF, DKIM, and DMARC validation

87/100
Score

No MTA-STS Policy

MEDIUM

MTA-STS enforces TLS for email delivery Unlock the full report to read the complete fix.

No TLS-RPT Record

LOW

TLS-RPT provides reporting for email TLS issues Unlock the full report to read the complete fix.

SPF
Sender Policy Framework
DKIM
DomainKeys Identified Mail
DMARC
Domain-based Message Authentication
MX Records
Mail Exchange Records
BIMI
Brand Indicators
MTA-STS
Mail Transfer Agent Security
TLS-RPT
TLS Reporting
DNSSEC
DNS Security
SPF Details
Record:
v=spf1 ip4:67.132.78.84 ip4:202.87.61.70 include:spf.protection.outlook.com include:spf-test.gps.ihost.com include:spf-prod.gps.ihost.com -all
DNS Lookups:3/10
Policy:-all
DKIM Selectors Found
Selector:selector1(1416-bit rsa)
DMARC Details
Policy:reject
Aggregate Reports:rua.sunpharma@progist.in
Forensic Reports:notes.admin@sunpharma.com

🏆SSL/TLS Security

Certificate validity and encryption analysis.

This is a teaser of the TLS audit. Unlock to view certificate chains, cipher support tables, and remediation steps.

SSL/TLS Security

Certificate validity and encryption analysis

67/100
Score

Weak Protocols Supported

HIGH

Server supports weak protocols: TLSv1.1 Unlock the full report to read the complete fix.

OCSP Stapling Not Enabled

LOW

OCSP stapling improves performance and privacy Unlock the full report to read the complete fix.

Certificate Transparency Not Implemented

LOW

Certificate is not logged in Certificate Transparency logs Unlock the full report to read the complete fix.

Mixed Content Detected

MEDIUM

14 resources loaded over insecure HTTP Unlock the full report to read the complete fix.

Partial SSL/TLS Assessment

LOW

Completed 3 of 4 security checks due to time constraints Unlock the full report to read the complete fix.

Protocol Support

TLSv1.3TLSv1.2TLSv1.1

OCSP Status

OCSP Stapling Disabled

📊DNS Health

DNS configuration and security assessment.

Unlock the full DNS posture audit to reveal misconfigurations, zone records, and actionable fixes.

DNS Health

DNS configuration and security assessment

85/100
Score

DNSSEC Not Enabled

MEDIUM

DNSSEC is not configured for this domain Unlock the full report to read the complete fix.

CAA Records Not Configured

LOW

Certificate Authority Authorization (CAA) records not found Unlock the full report to read the complete fix.

DNS Records

A Records:159.60.142.184
Name Servers:
dbru.br.ns.els-gms.att.netDNS only
dmtu.mt.ns.els-gms.att.netDNS only
MX Records:
0: taro-com.mail.protection.outlook.com
SOA:Serial: 115, TTL: 86400s

DNSSEC Status

DNSSEC Not Enabled

DNS Performance

Resolution Time:184ms

SPF Analysis

SPF Record:
v=spf1 ip4:67.132.78.84 ip4:202.87.61.70 include:spf.protection.outlook.com include:spf-test.gps.ihost.com include:spf-prod.gps.ihost.com -all

Network Security

Port scanning and network exposure analysis.

See a glimpse of exposed services. Unlock to access full port inventories, CVE lookups, and mitigation priorities.

Network Security

Port scanning and network exposure analysis

100/100
Score

Good Network Security Posture

LOW

No unnecessary services detected on common risky ports Unlock the full report to read the complete fix.

🔧Technical Analysis

Detailed technical findings and analysis from AI assessment.

Unlock to view the complete technical breakdown, stack fingerprinting, and hardening checklist.

Technical Analysis

Comprehensive security assessment findings

Additional Findings

Unlock the full Guard report to review the complete technical breakdown and AI recommendations.
⭐ Verified Community Reviews

What others say about taro.com

Share your experience to help others make informed decisions. We verify every review by email and publish it once our moderation team approves it.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

out of 5

0 reviews published

Loading reviews…

How did we do?

Your feedback directly shapes our roadmap. Rate the quality of this report, leave an optional comment, and let us know if you want our security specialists to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.

Analyze Another Website